The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
出版年份 2021 全文链接
标题
The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
作者
关键词
-
出版物
DRUG DISCOVERY TODAY
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-03-19
DOI
10.1016/j.drudis.2021.03.011
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tissue-resident memory T cells in breast cancer control and immunotherapy responses
- (2020) Ann Byrne et al. Nature Reviews Clinical Oncology
- Moving towards personalized treatments of immune-related adverse events
- (2020) Khashayar Esfahani et al. Nature Reviews Clinical Oncology
- Immuno-Oncology Biomarkers for Personalized Immunotherapy in Breast Cancer
- (2020) Vida Vafaizadeh et al. Frontiers in Cell and Developmental Biology
- PD-1/PD-L1 counterattack alliance: multiple strategies for treating triple-negative breast cancer
- (2020) Haiying Zhu et al. DRUG DISCOVERY TODAY
- Role of immune checkpoint inhibitors in the revolutionization of advanced melanoma care
- (2020) Sima Singh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
- (2019) Sherene Loi et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement
- (2019) Ramon Colomer et al. ONCOLOGIST
- Immune-checkpoint inhibition for metastatic triple-negative breast cancer: safety first?
- (2019) Nina D’Abreo et al. Nature Reviews Clinical Oncology
- Tissue-Resident Memory T Cells in Cancer Immunosurveillance
- (2019) Simone L. Park et al. TRENDS IN IMMUNOLOGY
- Immune checkpoint inhibitors: a promising anticancer therapy
- (2019) Sima Singh et al. DRUG DISCOVERY TODAY
- The breast tumor microenvironment: role in cancer development, progression and response to therapy
- (2018) Suruchi Mittal et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
- (2018) Peter Savas et al. NATURE MEDICINE
- Triple-negative breast cancers — a panoply of cancer types
- (2018) Fresia Pareja et al. Nature Reviews Clinical Oncology
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- T cell–induced CSF1 promotes melanoma resistance to PD1 blockade
- (2018) Natalie J. Neubert et al. Science Translational Medicine
- Nanoscale delivery systems for cancer immunotherapy
- (2018) Zejun Wang et al. Materials Horizons
- Putting the Immunologic Brakes on Cancer
- (2018) Jedd Wolchok CELL
- Targeting triple negative breast cancer with histone deacetylase inhibitors
- (2017) Palma Fedele et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer
- (2016) Jacqueline Tsai et al. ANNALS OF SURGICAL ONCOLOGY
- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint Inhibition
- (2016) Claire F. Friedman et al. Current Oncology Reports
- Immune cell quantitation in normal breast tissue lobules with and without lobulitis
- (2014) Amy C. Degnim et al. BREAST CANCER RESEARCH AND TREATMENT
- Tissue-Resident Memory T Cells
- (2014) Jason M. Schenkel et al. IMMUNITY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Molecular regulation of effector and memory T cell differentiation
- (2014) John T Chang et al. NATURE IMMUNOLOGY
- Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario
- (2014) M. Bonotto et al. ONCOLOGIST
- PD-L1 Expression in Triple-Negative Breast Cancer
- (2014) E. A. Mittendorf et al. Cancer Immunology Research
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Leukocyte composition of human breast cancer
- (2011) B. Ruffell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease
- (2010) W. Miehsler et al. Journal of Crohns & Colitis
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrins
- (2009) Malgorzata Barczyk et al. CELL AND TISSUE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now